{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:12:41Z","timestamp":1793819561881,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1053\/j.ajkd.2020.08.016","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:46:12Z","timestamp":1602866772000},"page":"427-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Strategies to Treat Obesity in Patients With CKD"],"prefix":"10.1053","volume":"77","author":[{"given":"Kiran","family":"Chintam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9945","key":"10.1053\/j.ajkd.2020.08.016_bib1","doi-asserted-by":"crossref","first-page":"P766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2020.08.016_bib2","series-title":"Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017\u20132018","author":"Hales","year":"2020"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib3","doi-asserted-by":"crossref","first-page":"F685","DOI":"10.1152\/ajprenal.00324.2007","article-title":"Adverse renal consequences of obesity","volume":"294","author":"Griffin","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S2213-8587(14)70065-8","article-title":"Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease","volume":"2","author":"de Vries","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.ajkd.2020.08.016_bib6","unstructured":"World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894.\u00a02000."},{"issue":"9403","key":"10.1053\/j.ajkd.2020.08.016_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.110.160747","article-title":"Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the \u201cobesity paradox?\u201d","volume":"56","author":"Agarwal","year":"2010","journal-title":"Hypertension"},{"issue":"21","key":"10.1053\/j.ajkd.2020.08.016_bib9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJM199005243222101","article-title":"The response to long-term overfeeding in identical twins","volume":"322","author":"Bouchard","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1053\/j.ajkd.2020.08.016_bib10","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","article-title":"Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management","volume":"137","author":"Neeland","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3945\/ajcn.112.047787","article-title":"Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults","volume":"97","author":"Katzmarzyk","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1053\/j.ajkd.2020.08.016_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2215\/CJN.07010716","article-title":"Comparison between different measures of body fat with kidney function decline and incident CKD","volume":"12","author":"Madero","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/oby.2007.632","volume":"15","author":"Klein","year":"2007","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.02.390","article-title":"Association of waist circumference and body mass index with all-cause mortality in CKD: the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study","volume":"58","author":"Kramer","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"15","key":"10.1053\/j.ajkd.2020.08.016_bib15","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jacc.2008.12.040","article-title":"Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease","volume":"53","author":"Postorino","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib16","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1111\/j.1600-6143.2010.03330.x","article-title":"Body mass index, waist circumference and mortality in kidney transplant recipients","volume":"10","author":"Kovesdy","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2020.08.016_bib17","doi-asserted-by":"crossref","first-page":"k5301","DOI":"10.1136\/bmj.k5301","article-title":"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","volume":"364","author":"Chang","year":"2019","journal-title":"BMJ"},{"issue":"21","key":"10.1053\/j.ajkd.2020.08.016_bib18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/2013.jamainternmed.85","article-title":"Body mass index in 1.2 million adolescents and risk for end-stage renal disease","volume":"172","author":"Vivante","year":"2012","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2213-8587(15)00128-X","article-title":"Association of age and BMI with kidney function and mortality: a cohort study","volume":"3","author":"Lu","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12882-019-1434-7","article-title":"Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases","volume":"20","author":"Elyan","year":"2019","journal-title":"BMC Nephrol"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2020.08.016_bib22","doi-asserted-by":"crossref","first-page":"iv160","DOI":"10.1093\/ndt\/gft286","article-title":"Overweight\/obesity revisited as a predictive risk factor in primary IgA nephropathy","volume":"28","author":"Berthoux","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are\u00a0predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2215\/CJN.02250409","article-title":"Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 4","key":"10.1053\/j.ajkd.2020.08.016_bib25","doi-asserted-by":"crossref","first-page":"iv82","DOI":"10.1093\/ndt\/gft302","article-title":"Effects of weight loss on renal function in obese CKD patients: a systematic review","volume":"28","author":"Bolignano","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ndt\/gfp640","article-title":"Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts","volume":"25","author":"Afshinnia","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/ajkd.2003.50039","article-title":"Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies","volume":"41","author":"Morales","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib28","doi-asserted-by":"crossref","first-page":"P801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.08.016_bib29","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc12-1846","article-title":"Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial","volume":"36","author":"Tirosh","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1681\/ASN.2017010020","article-title":"Metabolic effects of diet and exercise in patients with moderate to severe CKD: a randomized clinical trial","volume":"29","author":"Ikizler","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000188541","article-title":"Effects of body-weight loss and captopril treatment on proteinuria associated with obesity","volume":"70","author":"Praga","year":"1995","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/pmed.1999.0529","article-title":"Toward improved management of NIDDM: a randomized, controlled, pilot intervention using a lowfat, vegetarian diet","volume":"29","author":"Nicholson","year":"1999","journal-title":"Prev Med"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib33","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2215\/CJN.10141012","article-title":"Effects of exercise and lifestyle intervention on cardiovascular function in CKD","volume":"8","author":"Howden","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib34","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3945\/ajcn.113.060889","article-title":"Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts","volume":"98","author":"Jesudason","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ki.2014.83","article-title":"Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate","volume":"86","author":"Goraya","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/j.ajkd.2014.07.015","article-title":"Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial","volume":"65","author":"Greenwood","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2020.08.016_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"25","key":"10.1053\/j.ajkd.2020.08.016_bib38","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/CIRCULATIONAHA.118.036418","article-title":"Effects of liraglutide versus placebo on cardiovascular events in patients with type 2 diabetes mellitus and chronic kidney disease","volume":"138","author":"Mann","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.118.038341","article-title":"Lorcaserin and renal outcomes in obese and overweight patients in the CAMELLIA-TIMI 61 Trial","volume":"139","author":"Scirica","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1463-1326.2006.00618.x","article-title":"Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes","volume":"9","author":"Stenl\u00f6f","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.ajkd.2014.06.011","article-title":"Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: a randomized controlled pilot study","volume":"64","author":"MacLaughlin","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib43","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2020.08.016_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jama.2018.0245","article-title":"Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial","volume":"319","author":"Gardner","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib46","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/nep.13118","article-title":"Weight management strategies for those with chronic kidney disease: a consensus report from the Asia Pacific Society of Nephrology and Australia and New Zealand Society of Nephrology 2016 renal dietitians meeting","volume":"23","author":"Lambert","year":"2018","journal-title":"Nephrology (Carlton)"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib47","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jand.2018.05.023","article-title":"Medical nutrition therapy for patients with non-dialysis-dependent chronic kidney disease: barriers and solutions","volume":"118","author":"Kramer","year":"2018","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12882-019-1586-5","article-title":"Exercise therapy improves eGFR, and reduces blood pressure and BMI in non-dialysis CKD patients: evidence from a meta-analysis","volume":"20","author":"Zhang","year":"2019","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2014.09.017","article-title":"Exercise training in CKD: efficacy, adherence, and safety","volume":"65","author":"Howden","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"10.1053\/j.ajkd.2020.08.016_bib51","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14740338.2012.675326","article-title":"Anti-obesity drugs: a review about their effects and their safety","volume":"11","author":"Derosa","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib55","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/oby.22581","article-title":"Antiobesity medication use in 2.2 million adults across eight large health care organizations: 2009-2015","volume":"27","author":"Saxon","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib56","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP)","volume":"20","author":"Allison","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib58","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2018-01010","article-title":"Cardiovascular safety during and after use of phentermine and topiramate","volume":"104","author":"Ritchey","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2020.08.016_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/dom.13137","article-title":"Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"20","author":"Tran","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2215\/CJN.11881019","article-title":"Safety of liraglutide in type 2 diabetes and chronic kidney disease","volume":"15","author":"Mann","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfy407","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA","volume":"34","author":"Sarafidis","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"10077","key":"10.1053\/j.ajkd.2020.08.016_bib62","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2020.08.016_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819865398","article-title":"The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists","volume":"10","author":"van Baar","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"19","key":"10.1053\/j.ajkd.2020.08.016_bib65","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib67","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/obr.12755","article-title":"Weight loss associated with\u00a0sodium-glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms","volume":"19","author":"Lee","year":"2018","journal-title":"Obes Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2020.08.016_bib68","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/obr.12841","article-title":"Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: mechanistic possibilities","volume":"20","author":"Brown","year":"2019","journal-title":"Obes Rev"},{"issue":"24","key":"10.1053\/j.ajkd.2020.08.016_bib69","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib70","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S2213-8587(16)30267-4","volume":"4","author":"Fr\u00edas","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib71","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.2016.1558","article-title":"Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2020.08.016_bib72","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ekir.2018.07.020","article-title":"Secondary oxalate nephropathy: a systematic review","volume":"3","author":"Lumlertgul","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib73","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.ajkd.2020.08.016_bib74","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/M15-2650","article-title":"Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"164","author":"Maruthur","year":"2016","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib75","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/oby.22444","article-title":"Effect of obesogenic\u00a0medications on weight-loss outcomes in a behavioral weight-management program","volume":"27","author":"Desalermos","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib76","first-page":"1346","volume":"25","author":"Mechanick","year":"2019","journal-title":"Endocr Pract"},{"issue":"10","key":"10.1053\/j.ajkd.2020.08.016_bib77","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1053\/j.ajkd.2020.08.016_bib78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2020.08.016_bib79","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.kint.2016.02.039","article-title":"Bariatric surgery is associated with improvement in kidney outcomes","volume":"90","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/j.ajkd.2016.09.020","article-title":"Estimated GFR before and after bariatric surgery in CKD","volume":"69","author":"Imam","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib81","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41366-018-0045-x","article-title":"Incidence of end-stage renal disease following bariatric surgery in the Swedish Obese Subjects Study","volume":"42","author":"Shulman","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib82","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14670","article-title":"Association of bariatric surgery with rates of kidney function decline using multiple filtration markers","volume":"3","author":"Chang","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib83","first-page":"159","article-title":"Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology","volume":"30","author":"Bellizzi","year":"2017","journal-title":"J\u00a0Nephrol"},{"issue":"1 suppl 2","key":"10.1053\/j.ajkd.2020.08.016_bib84","first-page":"S66","article-title":"K\/DOQI clinical practice guidelines for nutrition in chronic renal failure","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ekir.2017.01.009","article-title":"The obesity paradox in kidney disease: how to reconcile it with obesity management","volume":"2","author":"Kalantar-Zadeh","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1053\/j.ajkd.2020.08.016_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114897","article-title":"The association between body mass index and mortality in incident dialysis patients","volume":"9","author":"Badve","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib87","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amjmed.2014.10.043","article-title":"Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias","volume":"128","author":"Lajous","year":"2015","journal-title":"Am J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2020.08.016_bib88","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwr384","article-title":"Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis","volume":"175","author":"Kalantar-Zadeh","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.08.016_bib89","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/ndt\/gfv214","article-title":"Recipient obesity and\u00a0outcomes after kidney transplantation: a systematic review and meta-analysis","volume":"30","author":"Hill","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2020.08.016_bib90","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/ajt.13363","article-title":"Kidney transplantation significantly improves patient and graft survival irrespective of\u00a0BMI: a cohort study","volume":"15","author":"Krishnan","year":"2015","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2020.08.016_bib91","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11695-018-3604-2","article-title":"National postoperative bariatric surgery outcomes in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Cohen","year":"2019","journal-title":"Obes Surg"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib92","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ajt.14463","article-title":"Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients","volume":"18","author":"Kim","year":"2018","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib93","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.soard.2014.09.022","article-title":"Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates","volume":"11","author":"Jamal","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2020.08.016_bib94","first-page":"472","article-title":"Participation in a structured weight loss program and all-cause mortality and cardiovascular morbidity in obese patients with chronic kidney disease","volume":"25","author":"MacLaughlin","year":"2015","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1053\/j.ajkd.2020.08.016_bib95","first-page":"334","article-title":"Is weight gain inevitable in most chronic peritoneal dialysis patients?","volume":"8","author":"Diaz-Buxo","year":"1992","journal-title":"Adv Perit Dial"},{"issue":"5","key":"10.1053\/j.ajkd.2020.08.016_bib96","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/ajt.13166","article-title":"Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomy","volume":"15","author":"Freeman","year":"2015","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2020.08.016_bib97","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/ajt.15650","article-title":"Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy","volume":"20","author":"Kassam","year":"2020","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2020.08.016_bib98","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2215\/CJN.01480219","article-title":"Trends in bariatric surgery procedures among patients with ESKD in the United States","volume":"14","author":"Sheetz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.08.016_bib99","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.soard.2019.04.002","article-title":"Bariatric surgery before and after kidney transplantation: long-term weight loss and allograft outcomes","volume":"15","author":"Cohen","year":"2019","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2020.08.016_bib100","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620310489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620310489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:32:29Z","timestamp":1759462349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620310489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0272638620310489"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.08.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to Treat Obesity in Patients With CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}